Aug 5, 2026 06:45AM
Aug 3, 2026 07:45AM
Aug 3, 2026 07:45AM
Jul 23, 2026 06:45AM
Jul 23, 2026 06:45AM
Jul 16, 2026 10:00AM
Jul 16, 2026 06:45AM Eli Lilly to acquire AtaiBeckley for up to $3.8B
Jul 16, 2026 06:45AM
Jul 15, 2026 10:42AM
Jul 14, 2026 02:27PM
Jul 13, 2026 03:27PM
Jul 9, 2026 07:31AM
Jul 9, 2026 07:30AM
Jul 9, 2026 07:30AM /C O R R E C T I O N -- Eli Lilly and Company/
Jul 1, 2026 09:05AM
Jun 29, 2026 04:29PM
Jun 29, 2026 04:20PM
Jun 29, 2026 06:14AM
Jun 26, 2026 07:17AM
Jun 26, 2026 07:16AM
Jun 25, 2026 06:45AM What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management
Jun 22, 2026 09:05AM
Jun 22, 2026 09:00AM
Jun 14, 2026 08:05AM
Jun 14, 2026 03:15AM
Jun 10, 2026 09:30AM
Jun 9, 2026 06:19PM
Jun 9, 2026 06:18PM FDA approves Lilly's EBGLYSS® (lebrikizumab-lbkz) for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis
Jun 8, 2026 02:31PM
Jun 8, 2026 02:30PM
Jun 8, 2026 02:56AM
Jun 7, 2026 11:00AM
Jun 6, 2026 02:53PM
Jun 6, 2026 02:30PM
Jun 4, 2026 08:03AM Weight Watchers integrates with Eli Lilly's LillyDirect platform
Jun 2, 2026 09:30AM
Jun 2, 2026 09:30AM
Jun 1, 2026 02:53AM
May 31, 2026 11:21PM
May 31, 2026 08:01AM
May 28, 2026 01:00PM
May 28, 2026 01:00PM Lilly to present new data on Foundayo, Mounjaro and retatrutide at the American Diabetes Association's 86th Scientific Sessions, building toward a new era of choice in diabetes and obesity care
May 28, 2026 06:47AM
May 28, 2026 06:45AM
May 26, 2026 05:50AM
May 25, 2026 08:45AM
May 21, 2026 05:02PM
May 21, 2026 05:00PM
May 21, 2026 06:45AM Lilly's retatrutide shows significant weight loss in phase 3 trial
May 21, 2026 06:45AM

327,805 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All